Literature DB >> 1380230

Macrophages in melanocytic naevi.

E B Bröcker1, C Reckenfeld, H Hamm, D J Ruiter, C Sorg.   

Abstract

Whereas the inflammatory infiltrates of malignant melanoma have been widely investigated, little is known about the infiltrates accompanying benign melanocytic naevi. Using monoclonal antibodies directed against HLA-DR antigens, the CD1 antigen, the transferrin receptor and functionally divergent macrophage subpopulations, frozen fresh material of 87 melanocytic naevi (MN), ten primary cutaneous melanomas (PCM) and ten samples of normal skin were studied. Compared with normal skin, abundant HLA-DR+ cells were found in the stroma of MN equivalent to the quantity present in PCM. In MN we found higher numbers of dermal CD1+ dendritic cells compared with PCM and normal skin. There were more macrophages that expressed the transferrin receptor or the antigens 27E10, RM3/1 and 25F9 in MN than in normal skin but fewer than in PCM. No significant differences were found between congenital MN (n = 40), common acquired MN (n = 27) and dysplastic MN (n = 20) macrophage subpopulations. Also, no correlations were evident between macrophage infiltrates and naevus location or patients' age. Our data show that potential melanoma precursors among melanocytic naevi cannot be identified by the pattern of macrophage infiltrates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1380230     DOI: 10.1007/bf00372703

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  24 in total

1.  A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulatory phase of the inflammatory process.

Authors:  G Zwadlo; R Voegeli; K Schulze Osthoff; C Sorg
Journal:  Exp Cell Biol       Date:  1987

2.  Relative increase of Langerhans cells in 'banal' and dysplastic melanocytic naevi.

Authors:  W Sterry; T Henseler; F W Pehlemann; D Schlegel
Journal:  Br J Dermatol       Date:  1987-04       Impact factor: 9.302

3.  A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes.

Authors:  G Zwadlo; E B Bröcker; D B von Bassewitz; U Feige; C Sorg
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

4.  Langerhans' cells and T cells in human skin tumours: an immunohistological study.

Authors:  K C Gatter; H B Morris; B Roach; P Mortimer; K A Fleming; D Y Mason
Journal:  Histopathology       Date:  1984-03       Impact factor: 5.087

5.  Quantitative alterations in cutaneous Langerhans cells during the evolution of malignant melanoma of the skin.

Authors:  M A Stene; M Babajanians; S Bhuta; A J Cochran
Journal:  J Invest Dermatol       Date:  1988-08       Impact factor: 8.551

6.  Langerhans cells in various benign and malignant pigment-cell lesions of the skin.

Authors:  F Facchetti; C de Wolf-Peeters; H de Greef; V J Desmet
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  T cell subsets and Langerhans cells in skin tumours.

Authors:  R Fernandez-Bussy; F Cambazard; G Mauduit; D Schmitt; J Thivolet
Journal:  Eur J Cancer Clin Oncol       Date:  1983-07

8.  Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.

Authors:  D J Ruiter; A K Bhan; T J Harrist; A J Sober; M C Mihm
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.

Authors:  M J Kornstein; J S Brooks; D E Elder
Journal:  Cancer Res       Date:  1983-06       Impact factor: 12.701

10.  Inflammatory cell infiltrates in human melanoma at different stages of tumor progression.

Authors:  E B Bröcker; G Zwadlo; B Holzmann; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1988-04-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.